ASHOKLEY - To hit 290 in the coming weeks?
Updated
Ashok Leyland - CMP 222
The stock looks ready for a good upmove provided the recent swing low of 200 holds
Wave counts and technical Patterns (Rounding Bottom breakout) everything points the target towards 290 for the short-medium term
Refer to the chart for counts on various Degree/TF and Technical Patterns
Vth of Primary 3rd is now underway.
On hourly TF, price broke above the falling trendline and broke the LH/LL structure..
There could be one more dip towards 210 levels.. and thereby make a double bottom structure
but this current impulse could take the script to AVWAP from the TOP at 230 levels..
A good script to consider for Dec/Jan series
The stock looks ready for a good upmove provided the recent swing low of 200 holds
Wave counts and technical Patterns (Rounding Bottom breakout) everything points the target towards 290 for the short-medium term
Refer to the chart for counts on various Degree/TF and Technical Patterns
Vth of Primary 3rd is now underway.
On hourly TF, price broke above the falling trendline and broke the LH/LL structure..
There could be one more dip towards 210 levels.. and thereby make a double bottom structure
but this current impulse could take the script to AVWAP from the TOP at 230 levels..
A good script to consider for Dec/Jan series
Trade active
Price tested 230.45 and got rejected from the AVWAP from the TOP as anticipated.. CMP is 223.8. Price could again give a bounce from 220-222 levels and break the swing high at 230.65 to validate the HH and HL structure.. A fall from there could give us a decent RR trade.. Wait for Sub 220 levels.. thats my view on this script.. please consult your Financial Advisor before making any investment decisions.. Views are for educational purpose only.. I am not SEBI Registered
I am not a SEBI Registered Analyst. Views are personal and for Education purpose only. Please consult your Financial Analyst before making investment decision
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.